GKB Ophthalmics

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE265D01015
  • NSEID: GKB
  • BSEID: 533212
INR
57.40
2.56 (4.67%)
BSENSE

Apr 02

BSE+NSE Vol: 19.75 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 360373,
    "name": "GKB Ophthalmics",
    "stock_name": "GKB Ophthalmics",
    "full_name": "GKB Ophthalmics Ltd",
    "name_url": "stocks-analysis/gkb-ophthalmics",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "57.40",
    "chg": 2.56,
    "chgp": "4.67%",
    "dir": 1,
    "prev_price": "54.84",
    "mcapval": "28.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 533212,
    "symbol": "GKB",
    "ind_name": "Healthcare Services",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE265D01015",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "19.75 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/gkb-ophthalmics-360373-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 60,
    "sid": "360373",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/gkb-ophthalmics-360373"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015 as amended from time to time the Trading Window for dealing / trading in the shares of the Company shall remain closed from April 012026 till completion of 48 hours after the declaration of the audited financial results of the Company for the quarter and financial year ended March 31 2026. Accordingly all the Promoters Directors and Designated Persons of he Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company during the periods of closure of Trading Window. Further the date of Board Meeting at which the said results will be considered shall be intimated in due course of time. Kindly take the information on record.",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of Independent Directors Meeting Held On March 18 2026",
      "datetime": "18-Mar-2026",
      "details": "A Seperate meeting of Independent Directors Meeting of the Company for the year 2025-26 was held pursuant to Regulation 25(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 and Section 149 (8) of the Companies Act 2013 read with Schedule IV (VII). The Independent Directors Meeting started at 3.00 P.M and ended at 4.10 P.M. on the same day. Kindly take the information on record.",
      "source": "BSE"
    },
    {
      "caption": "Notice Of The Independent Directors Meeting",
      "datetime": "09-Mar-2026",
      "details": "Notice is hereby given that pursuant to Regulation 25 (3 & 4) of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015 and Schedule IV clause VII of the Companies Act 2013 a separate meeting of the independent directors of GKB Ophthalmics Limited will be held on Wednesday March 18 2026 at the Registered office of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "GKB Ophthalmics Ltd has declared <strong>12%</strong> dividend, ex-date: 21 Sep 10",
          "dt": "2010-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Closure of Trading Window

25-Mar-2026 | Source : BSE

Pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015 as amended from time to time the Trading Window for dealing / trading in the shares of the Company shall remain closed from April 012026 till completion of 48 hours after the declaration of the audited financial results of the Company for the quarter and financial year ended March 31 2026. Accordingly all the Promoters Directors and Designated Persons of he Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company during the periods of closure of Trading Window. Further the date of Board Meeting at which the said results will be considered shall be intimated in due course of time. Kindly take the information on record.

Outcome Of Independent Directors Meeting Held On March 18 2026

18-Mar-2026 | Source : BSE

A Seperate meeting of Independent Directors Meeting of the Company for the year 2025-26 was held pursuant to Regulation 25(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 and Section 149 (8) of the Companies Act 2013 read with Schedule IV (VII). The Independent Directors Meeting started at 3.00 P.M and ended at 4.10 P.M. on the same day. Kindly take the information on record.

Notice Of The Independent Directors Meeting

09-Mar-2026 | Source : BSE

Notice is hereby given that pursuant to Regulation 25 (3 & 4) of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015 and Schedule IV clause VII of the Companies Act 2013 a separate meeting of the independent directors of GKB Ophthalmics Limited will be held on Wednesday March 18 2026 at the Registered office of the Company.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

GKB Ophthalmics Ltd has declared 12% dividend, ex-date: 21 Sep 10

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available